Record high FIIs stake in this multibagger pharma stock: Exploring the key tailwinds! Record high FIIs stake in this multibagger pharma stock: Exploring the key tailwinds! The company saw strong volume growth across key markets, particularly the US, indicating rising demand for their products. Aniket Gogate / Wednesday, February 21, 2024 / Article rating: 4.0 Institutional investor interest in the stock has risen significantly, with Foreign Institutional Investor (FII) holdings increasing to 15.55 per cent in the quarter ending December 2023 from 4.23 per cent in December 2022.